
display increased nephrotoxicity. Additional nephroprotection through further reduction in osmolality was suggested by a study comparing iohexol (Omnipaque, a
low-osmolar agent; 600-800 mOsm/kg) with iodixanol
(Visipaque, an iso-osmolar agent; 290 mOsm/kg).137
However, rates of CIN for iopamidol